Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ischemia-reperfusion injury: evidences for translational research.

Literature DB >> 27868023

Ischemia-reperfusion injury: evidences for translational research.

Francesco Bellanti¹.

Abstract

Entities: Disease

Year: 2016 PMID： 27868023 PMCID： PMC5104605 DOI： 10.21037/atm.2016.10.52

Source DB: PubMed Journal: Ann Transl Med ISSN： 2305-5839

× No keyword cloud information.

17 in total

Review 1. Clinical evaluation of a neuroprotective drug in patients with cervical spondylotic myelopathy undergoing surgical treatment: design and rationale for the CSM-Protect trial.

Authors: Michael G Fehlings; Jefferson R Wilson; Spyridon K Karadimas; Paul M Arnold; Branko Kopjar
Journal: Spine (Phila Pa 1976) Date: 2013-10-15 Impact factor: 3.468

2. Riluzole improves outcome following ischemia-reperfusion injury to the spinal cord by preventing delayed paraplegia.

Authors: Y Wu; K Satkunendrarajah; M G Fehlings
Journal: Neuroscience Date: 2014-02-06 Impact factor: 3.590

Review 3. Cell biology of ischemia/reperfusion injury.

Authors: Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal: Int Rev Cell Mol Biol Date: 2012 Impact factor: 6.813

4. Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease.

Authors: Kori L Wallace; Joel Linden
Journal: Blood Date: 2010-08-26 Impact factor: 22.113

5. Riluzole improves functional recovery after ischemia in the rat retina.

Authors: M Ettaiche; K Fillacier; C Widmann; C Heurteaux; M Lazdunski
Journal: Invest Ophthalmol Vis Sci Date: 1999-03 Impact factor: 4.799

6. Effects of riluzole on P2X7R expression in the spinal cord in rat model of neuropathic pain.

Authors: Kai Jiang; Ying Zhuang; Ming Yan; Hui Chen; An-Qi Ge; Li Sun; Bei Miao
Journal: Neurosci Lett Date: 2016-03-04 Impact factor: 3.046

7. Toll-like receptor 4-dependent microglial activation mediates spinal cord ischemia-reperfusion injury.

Authors: Marshall T Bell; Ferenc Puskas; Viktor A Agoston; Joseph C Cleveland; Kirsten A Freeman; Fabia Gamboni; Paco S Herson; Xianzhong Meng; Phillip D Smith; Michael J Weyant; David A Fullerton; T Brett Reece
Journal: Circulation Date: 2013-09-10 Impact factor: 29.690

8. Oxidative damage in clinical ischemia/reperfusion injury: a reappraisal.

Authors: Dorottya K de Vries; Kirsten A Kortekaas; Dimitrios Tsikas; Leonie G M Wijermars; Cornelis J F van Noorden; Maria-Theresia Suchy; Christa M Cobbaert; Robert J M Klautz; Alexander F M Schaapherder; Jan H N Lindeman
Journal: Antioxid Redox Signal Date: 2013-03-26 Impact factor: 8.401

6. Near-infrared fluorescence imaging with indocyanine green for assessment of donor livers in a rat model of ischemia-reperfusion.

Authors: Liyu Shan; Huan Chen; Lifei Yang; Zhe Feng; Yue Wang; Rongfeng Wang; Nana Zhang; Rongqian Wu; Yi Lv; Tao Ma
Journal: BMC Gastroenterol Date: 2022-01-20 Impact factor: 3.067

6 in total

Ischemia-reperfusion injury: evidences for translational research.

Review 1. Clinical evaluation of a neuroprotective drug in patients with cervical spondylotic myelopathy undergoing surgical treatment: design and rationale for the CSM-Protect trial.

2. Riluzole improves outcome following ischemia-reperfusion injury to the spinal cord by preventing delayed paraplegia.

Review 3. Cell biology of ischemia/reperfusion injury.

4. Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease.

5. Riluzole improves functional recovery after ischemia in the rat retina.

6. Effects of riluzole on P2X7R expression in the spinal cord in rat model of neuropathic pain.

7. Toll-like receptor 4-dependent microglial activation mediates spinal cord ischemia-reperfusion injury.

8. Oxidative damage in clinical ischemia/reperfusion injury: a reappraisal.

9. Evaluation of spinal cord injury animal models.

Review 10. Riluzole as a neuroprotective drug for spinal cord injury: from bench to bedside.

Review 1. Tissue Dependent Role of PTX3 During Ischemia-Reperfusion Injury.

2. Redox Control of the Immune Response in the Hepatic Progenitor Cell Niche.

3. Astaxanthin Relieves Testicular Ischemia-Reperfusion Injury-Immunohistochemical and Biochemical Analyses.

4. The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice.

5. Neuroprotective effect of menaquinone-4 (MK-4) on transient global cerebral ischemia/reperfusion injury in rat.

6. Near-infrared fluorescence imaging with indocyanine green for assessment of donor livers in a rat model of ischemia-reperfusion.